Retroperitoneal Lymphadenectomy for Testicular Tumors

Patrick C. Walsh, Joseph J. Kaufman, Walter F. Coulson, Willard E. Goodwin

Research output: Contribution to journalArticlepeer-review


Sixty-four patients have been observed for three years or more after radical lymphadenectomy for nonseminomatous germinal-cell tumors of the testis. The results of this study indicate that survival rates of patients with stage A teratocarcinoma and embryonal carcinoma were excellent (93% and 94%, respectively). In patients with stage B tumors, survival rates were far better in the teratocarcinoma group (77%) than in patients with embryonal carcinoma (29%). The study failed to document the value of postlymphadenectomy radiation therapy for either embryonal carcinoma or teratocarcinoma. Furthermore, there appears to be no advantage to bilateral lymphadenectomy over unilateral lymph-node dissection. Results from studies employing either the lumbar approach or transperitoneal approach appear to be equal.

Original languageEnglish (US)
Pages (from-to)309-312
Number of pages4
JournalJAMA: The Journal of the American Medical Association
Issue number3
StatePublished - Jul 19 1971
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Retroperitoneal Lymphadenectomy for Testicular Tumors'. Together they form a unique fingerprint.

Cite this